Tianjin Institute of Pharmaceutical Research Co., Ltd.was founded in 1959, it is one of the national comprehensive pharmaceutical research units directly under the former National Medical Administration. In 2000, it was restructured and entered the state-owned assets system of Tianjin. In 2018, it passed the mixed ownership reform of state-owned enterprises and became a modern research and development pharmaceutical enterprise under the China Merchants Group. The company has multiple research and development and production manufacturers of APIs. The main APIs products of the company include: Gliquidone, Glipizide, Minoxidil, Febuxostat, Procaterol Hydrochloride, Tenofovir Alafenamide Fumarate, Peramivir, Relugolix, etc.